PDS Biotechnology Corp Investment Income, Interest
PDS Biotechnology Corp (PDSB) reported Investment Income, Interest of $125.41 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- PDS Biotechnology Corp investment income, interest for the quarter ending 2026-06-30 was $125.41K, a 62.41% decline year-over-year.
- PDS Biotechnology Corp investment income, interest for the quarter ending 2026-03-31 was $186.81K, a 50.56% decline year-over-year.
- PDS Biotechnology Corp investment income, interest for the quarter ending 2025-12-31 was $224.66K, a 55.42% decline year-over-year.
- PDS Biotechnology Corp investment income, interest for the quarter ending 2025-09-30 was $281.11K, a 57.84% decline year-over-year.
- PDS Biotechnology Corp investment income, interest for fiscal 2025 was $1.22M, a 51.60% decline from fiscal 2024.
- PDS Biotechnology Corp investment income, interest for fiscal 2024 was $2.51M, a 13.37% decline from fiscal 2023.
- PDS Biotechnology Corp investment income, interest for fiscal 2023 was $2.90M, a 210.42% increase from fiscal 2022.
- PDS Biotechnology Corp investment income, interest for fiscal 2022 was $935.18K, a 21418.18% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $125.41K 10-Q · filed 2026-08-13 | $312.22K 10-Q · filed 2026-08-13 | $536.88K derived: sum of 3 quarters · filed 2026-08-13 | $817.99K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $186.81K 10-Q · filed 2026-05-14 | $411.47K derived: sum of 2 quarters · filed 2026-05-14 | $692.58K derived: sum of 3 quarters · filed 2026-05-14 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $224.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $505.77K derived: sum of 2 quarters · filed 2026-03-30 | $839.39K derived: sum of 3 quarters · filed 2026-08-13 | $1.22M 10-K · filed 2026-03-30 |
| 2025-09-30 | $281.11K 10-Q · filed 2025-11-13 | $614.73K derived: sum of 2 quarters · filed 2026-08-13 | $992.58K 10-Q · filed 2025-11-13 | $1.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $333.62K 10-Q · filed 2026-08-13 | $711.47K 10-Q · filed 2026-08-13 | $1.22M derived: sum of 3 quarters · filed 2026-08-13 | $1.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $377.85K 10-Q · filed 2026-05-14 | $881.79K derived: sum of 2 quarters · filed 2026-05-14 | $1.55M derived: sum of 3 quarters · filed 2026-05-14 | $2.22M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $503.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.17M derived: sum of 2 quarters · filed 2026-03-30 | $1.85M derived: sum of 3 quarters · filed 2026-03-30 | $2.51M 10-K · filed 2026-03-30 |
| 2024-09-30 | $666.77K 10-Q · filed 2025-11-13 | $1.34M derived: sum of 2 quarters · filed 2025-11-13 | $2.01M 10-Q · filed 2025-11-13 | $2.69M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $675.21K 10-Q · filed 2025-08-13 | $1.34M 10-Q · filed 2025-08-13 | $2.03M derived: sum of 3 quarters · filed 2025-08-13 | $2.77M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $668.89K 10-Q · filed 2025-05-14 | $1.35M derived: sum of 2 quarters · filed 2025-05-14 | $2.09M derived: sum of 3 quarters · filed 2025-05-14 | $2.84M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $683.54K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.42M derived: sum of 2 quarters · filed 2025-03-27 | $2.17M derived: sum of 3 quarters · filed 2025-03-27 | $2.90M 10-K · filed 2025-03-27 |
| 2023-09-30 | $739.40K 10-Q · filed 2024-11-14 | $1.49M derived: sum of 2 quarters · filed 2024-11-14 | $2.22M 10-Q · filed 2024-11-14 | $2.82M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $750.65K 10-Q · filed 2024-08-13 | $1.48M 10-Q · filed 2024-08-13 | $2.08M derived: sum of 3 quarters · filed 2024-08-13 | $2.33M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $729.34K 10-Q · filed 2024-05-15 | $1.33M derived: sum of 2 quarters · filed 2024-05-15 | $1.58M derived: sum of 3 quarters · filed 2024-05-15 | $1.66M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $602.86K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $854.93K derived: sum of 2 quarters · filed 2024-03-28 | $929.48K derived: sum of 3 quarters · filed 2024-03-28 | $935.18K 10-K · filed 2024-03-28 |
| 2022-09-30 | $252.07K 10-Q · filed 2023-11-14 | $326.62K derived: sum of 2 quarters · filed 2023-11-14 | $332.32K 10-Q · filed 2023-11-14 | $334.05K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $74.55K 10-Q · filed 2023-08-14 | $80.25K 10-Q · filed 2023-08-14 | $81.98K derived: sum of 3 quarters · filed 2023-08-14 | $83.33K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $5.70K 10-Q · filed 2023-05-15 | $7.43K derived: sum of 2 quarters · filed 2023-05-15 | $8.79K derived: sum of 3 quarters · filed 2023-05-15 | $9.39K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.73K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $3.09K derived: sum of 2 quarters · filed 2023-03-28 | $3.69K derived: sum of 3 quarters · filed 2023-03-28 | $4.35K 10-K · filed 2023-03-28 |
| 2021-09-30 | $1.36K 10-Q · filed 2021-11-10 | $1.96K derived: sum of 2 quarters · filed 2022-08-08 | $2.62K 10-Q · filed 2021-11-10 | $3.38K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | $604.00 10-Q · filed 2022-08-08 | $1.26K 10-Q · filed 2022-08-08 | $2.02K derived: sum of 3 quarters · filed 2022-08-08 | $3.23K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $655.00 10-Q · filed 2022-05-11 | $1.42K derived: sum of 2 quarters · filed 2022-05-11 | $2.63K derived: sum of 3 quarters · filed 2022-05-11 | $9.24K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $764.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.97K derived: sum of 2 quarters · filed 2022-03-31 | $8.59K derived: sum of 3 quarters · filed 2022-03-31 | $55.01K 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.21K 10-Q · filed 2021-11-10 | $7.82K derived: sum of 2 quarters · filed 2021-11-10 | $54.24K 10-Q · filed 2021-11-10 | $113.04K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $6.62K 10-Q · filed 2021-08-12 | $53.04K 10-Q · filed 2021-08-12 | $111.83K derived: sum of 3 quarters · filed 2021-08-12 | $207.62K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $46.42K 10-Q · filed 2021-05-13 | $105.22K derived: sum of 2 quarters · filed 2021-05-13 | $201.00K derived: sum of 3 quarters · filed 2021-05-13 | $376.61K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $58.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $154.58K derived: sum of 2 quarters · filed 2021-03-18 | $330.19K derived: sum of 3 quarters · filed 2021-03-18 | $353.49K 10-K · filed 2021-03-18 |
| 2019-09-30 | $95.79K 10-Q · filed 2020-11-13 | $271.39K derived: sum of 2 quarters · filed 2020-11-13 | $294.69K 10-Q · filed 2020-11-13 | $294.68K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $175.60K 10-Q · filed 2020-08-13 | $198.91K 10-Q · filed 2020-08-13 | $198.89K derived: sum of 3 quarters · filed 2020-08-13 | $198.90K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $23.30K 10-Q · filed 2020-05-13 | $23.29K derived: sum of 2 quarters · filed 2020-05-13 | $23.29K derived: sum of 3 quarters · filed 2020-05-13 | $23.30K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$14.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$10.00 derived: sum of 2 quarters · filed 2020-03-27 | -$6.00 derived: sum of 3 quarters · filed 2020-03-27 | $0.00 10-K · filed 2020-03-27 |
| 2018-09-30 | $4.00 10-Q · filed 2019-11-07 | $8.00 derived: sum of 2 quarters · filed 2019-11-07 | $14.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $4.00 10-Q · filed 2019-08-01 | $10.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $6.00 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |